Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neoplasms × Radiomics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Adenocarcinoma of Lung 2 Uterine Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Radiomics 1 Prostatic Neoplasms 1 Pituitary Diseases 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Lung Neoplasms 1 Lung Diseases 1 Liver Cirrhosis 1 Hepatitis B 1 Head and Neck Neoplasms 1 Disease Progression 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Gemcitabine 601 130-nm albumin-bound paclitaxel 168 Fluorouracil 161 Oxaliplatin 147 Albumin-Bound Paclitaxel 131 Capecitabine 117 Leucovorin 113 Irinotecan 98 Radiotherapy 89 Taxes 74 pembrolizumab 70 Cisplatin 68 Erlotinib Hydrochloride 63 Radiosurgery 60 Bevacizumab 48 Nivolumab 46 Magnetic Resonance Spectroscopy 44 Cyclophosphamide 44 Drug Therapy 42 Docetaxel 37 Specimen Handling 36 folfirinox 35 Cetuximab 35 irinotecan sucrosofate 33 S 1 (combination) 33 Biopsy 32 Pancreaticoduodenectomy 29 Paclitaxel 28 Blood Specimen Collection 28 Radiation 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05298722 2025-04-02

PeRFormanCe

University Hospital, Ghent

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡